{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:38:41Z","timestamp":1788284321180,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1023\/a:1014615517996","type":"journal-article","created":{"date-parts":[[2002,12,28]],"date-time":"2002-12-28T16:18:52Z","timestamp":1041092332000},"page":"181-188","source":"Crossref","is-referenced-by-count":39,"title":["Visual field and electrophysiological abnormalities due to vigabatrin"],"prefix":"10.1007","volume":"104","author":[{"given":"Kors","family":"van der Torren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hellen S.","family":"Graniewski-Wijnands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.C.P.","family":"Polak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"360497_CR1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bmj.314.7075.180","volume":"314","author":"T Eke","year":"1997","unstructured":"Eke T, Talbot JF, Lawden MC. Severe persistent visual field constriction associated with vigabatrin. Br Med J 1997; 314: 180\u20131.","journal-title":"Br Med J"},{"key":"360497_CR2","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1002\/(SICI)1099-1557(199904)8:1+<S9::AID-PDS406>3.0.CO;2-C","volume":"8","author":"LV Wilton","year":"1999","unstructured":"Wilton LV, Stephens MOB, Mann RD. Visual field defect associated with vigabatrin: observational cohort study. Pharmacol. Epidemiol. Drug Safety 1999; 8: S9\u201314.","journal-title":"Pharmacol. Epidemiol. Drug Safety"},{"key":"360497_CR3","first-page":"1694","volume":"314","author":"N. Blackwell","year":"1997","unstructured":"Blackwell N. Severe persistent visual field constriction associated with vigabatrin. Patients taking vigabatrin should have regular visual field testing. Br Med J 1997; 314: 1694.","journal-title":"Br Med J"},{"key":"360497_CR4","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1136\/bmj.314.7087.1130","volume":"314","author":"GF. Harding","year":"1997","unstructured":"Harding GF. Severe persistent visual field constriction associated with vigabatrin. Four possible explanations exist. Br Med J 1997; 314: 1694.","journal-title":"Br Med J"},{"key":"360497_CR5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/jnnp.67.6.716","volume":"67","author":"MC Lawden","year":"1999","unstructured":"Lawden MC, Eke T, Degg C, Harding GFA, Wild JM. Visual field defects associated with vigabatrin therapy. J Neurol Neurosurg Psychiatry 1999; 67: 716\u201322.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"360497_CR6","unstructured":"Hardus P, Verduin WM, Postma G, Stilma JS, Berenschot TTJM, van Veelen CWM. Long-term changes in visual fields of patients with temporal lobe epilepsy using vigabatrin. In press."},{"key":"360497_CR7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0304-3940(89)90368-6","volume":"98","author":"MJ Neal","year":"1989","unstructured":"Neal MJ, Cunningham JR, Shah MA, Yazulla S. Immunocytochemical evidence that vigabatrin in rats causes GABA accumulation in glial cells of the retina. Neurosci Lett 1989; 98: 29\u201332.","journal-title":"Neurosci Lett"},{"key":"360497_CR8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0042-6989(88)90147-2","volume":"2","author":"I Gottlob","year":"1988","unstructured":"Gottlob I, Wundsch L, Tuppy FK. The rabbit electroretinogram: effect of GABA and its antagonists. Vis Res 1988; 2: 203\u201310.","journal-title":"Vis Res"},{"key":"360497_CR9","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1152\/jn.1998.79.3.1384","volume":"79","author":"T Euler","year":"1998","unstructured":"Euler T, Wassle H. Different contributions of GABAa and GABAc receptors to rod and cone bipolar cells in rat retinal slice preparation. J Neurophys 1998; 79: 1384\u201395.","journal-title":"J Neurophys"},{"key":"360497_CR10","first-page":"222","volume":"37","author":"H Qqian","year":"1996","unstructured":"Qqian H, Malchow RL, Chappell RL, Ripps H. The GABA receptors of skate Muller cells. Brain Res J 1996; 37: 222\u20133.","journal-title":"Brain Res J"},{"key":"360497_CR11","first-page":"89","volume":"66","author":"A Bayer","year":"1995","unstructured":"Bayer A, Thiel H-J, Zrenner E, Paulus W, Ried S. Schmidt D. Colour vision deficiencies and enhanced sensitivity to glare in epileptic patients treated with carbamazepine and phenytoin: ocular side effects of antiepileptic drug. Nervenarz 1995; 66: 89\u201396.","journal-title":"Nervenarz"},{"key":"360497_CR12","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1212\/WNL.52.6.1201","volume":"52","author":"CF Arndt","year":"1999","unstructured":"Arndt CF, Derambure P, Defoort-Ohellemes S, Hache JC. Outer retinal dysfunction in patients treated with vigabatrin. Neurology 1999; 52: 1201\u20135.","journal-title":"Neurology"},{"key":"360497_CR13","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/S0161-6420(99)90345-7","volume":"106","author":"H Daneshvar","year":"1999","unstructured":"Daneshvar H, Racette L, Coupland S, Kertes PJ, Gubermann A, Zackon D. Symptomatic and asymptomatic visual loss in patients taking vigabatrin. Ophthalmology 1999; 106: 1792\u20138.","journal-title":"Ophthalmology"},{"key":"360497_CR14","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1212\/WNL.50.3.614","volume":"50","author":"GL Krauss","year":"1998","unstructured":"Krauss GL, Johnson MA, Miller NR. Vigabatrin associated retinal cone system dysfunction. Electroretinogram and ophthalmic findings. Neurology 1998; 50: 614\u20138.","journal-title":"Neurology"},{"key":"360497_CR15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0166-2236(95)93886-3","volume":"18","author":"BA. Mustafa","year":"1995","unstructured":"Mustafa BA. Diversity of GABA receptors in the vertebrate outer retina. Trends Neurosci 1995; 18: 118\u201320.","journal-title":"Trends Neurosci"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1014615517996.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1014615517996\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1014615517996.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T04:19:10Z","timestamp":1753762750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1014615517996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["360497"],"URL":"https:\/\/doi.org\/10.1023\/a:1014615517996","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}